Skip to Main Content
Surgery
YSM Home

INFORMATION FOR

Diseases of the Cardiovascular System

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

What is the purpose of this trial?

Prospective, Multicenter, Double-blind, Randomized, Study to Evaluate DrugSorb-ATR Removal of Apixaban and Rivaroxaban to Reduce Likelihood of Serious Bleeding in Patients Undergoing Urgent Cardiothoracic Surgery

  • Trial with
    CytoSorbents, Inc.
  • Ages
    18 years and older
  • Gender
    Both
Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Ricarda Tomlin

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Sub-Investigators

  • Last Updated
    01/08/2024
  • Study HIC
    #2000031974

Contact Information

For more information about this study, including how to volunteer, contact Ricarda Tomlin